Cooperative Agreement U2GPS000803

This $550,000 Project Grant awarded by the National Science Foundation (NSF) under the Technology, Innovation, and Partnerships (CFDA 47.084) program supports the development of a remote monitoring system to reduce infections among patients undergoing peritoneal dialysis (PD). The project aims to enable real-time, continuous, and quantitative monitoring of biomarkers in dialysate to facilitate early detection and diagnosis of PD-associated infections. To achieve this, the project team will:...

This National Science Foundation (NSF) Technology, Innovation, and Partnerships (CFDA 47.084) Project Grant award supports the development of a novel device that can rapidly and automatically extract pathogen DNA from whole blood samples to enable faster diagnosis of sepsis. The $274,858 award to New England Hemolytics, Inc., with a project period from September 1, 2024 to February 28, 2025, will fund the testing and optimization of this technology across common sepsis-causing pathogens. The...

This National Science Foundation (NSF) Technology, Innovation, and Partnerships (CFDA 47.084) Project Grant award of $275,000 to Macula Vision Systems Inc., a for-profit organization, supports the development of a novel microscopy platform to automate the interpretation of microbiology lab tests performed in hospitals. The project aims to address the shortage of trained lab technicians by engineering a specialized light source, customized camera, and AI-enabled algorithms to analyze...

The National Science Foundation (NSF) awarded a $550,000 Project Grant under the NSF Technology, Innovation, and Partnerships (CFDA 47.084) program to George Washington University to develop a system for utilization-driven management of critical medical equipment, specifically infusion pumps, to improve patient safety and hospital efficiency. The project aims to leverage infusion pump utilization data, advanced analytics, and reliability engineering techniques to enable hospitals to optimize...

This $587,500 Cooperative Agreement award from the Centers for Disease Control and Prevention's (CDC) Global AIDS Program (CFDA 93.067) supports efforts by the Cameroon Baptist Convention Health Board to strengthen public health laboratory systems in Cameroon under the President's Emergency Plan for AIDS Relief (PEPFAR) program. The award period runs from October 2024 through September 2027. Key activities include implementing comprehensive HIV services, strengthening laboratory...

Summary SKM Instruments, LLC received a $572,722 Project Grant from the Centers for Disease Control and Prevention (CDC) Investigations and Technical Assistance program (CFDA 93.283) awarded on September 30, 2025, with performance completion targeted for May 31, 2026. The project focuses on developing an ultra-rapid optical platform for antimicrobial susceptibility testing (AST) of pulmonary non-tuberculous mycobacterial (NTM) infections. This technology platform represents an innovative...

The National Science Foundation awarded a $255,957 STTR Phase I Project Grant to CHS Healthcare Ventures Inc., doing business as Lightengale, to develop a lighted infusion line to optimize care and decrease complications for critically ill patients in infectious isolation situations such as COVID-19. The grant is funded through the NSF's Technology, Innovation, and Partnerships program (CFDA 47.084) and aims to advance science and engineering research leading to breakthrough technologies and...

This $991,832 Cooperative Agreement awarded by the National Science Foundation (NSF) under the Technology, Innovation, and Partnerships (CFDA 47.084) program supports the development of a novel rapid antibiotic susceptibility testing (AST) platform by Astek Diagnostics Inc., a minority-owned small business in Halethorpe, Maryland. The project aims to adapt the company's previously developed urine cartridge technology for use with cerebrospinal fluid and wound effluent specimens, characterize...

Federal Grant Award Summary Pace Diagnostics, Inc. received a $600,000 Project Grant award from the Centers for Disease Control and Prevention (CDC) Investigations and Technical Assistance program (CFDA 93.283) effective September 30, 2025, with a completion date of March 31, 2026. The award supports the development of an ultrasensitive urine tuberculosis antigen rapid detection test designed to improve the diagnosis of active tuberculosis. This innovation addresses a critical public health need...

This National Science Foundation (NSF) Technology, Innovation, and Partnerships (CFDA 47.084) Cooperative Agreement award of $984,381 to Cobio Diagnostics Inc. in Aurora, Colorado aims to expand a diagnostic tool that enables rapid, direct-from-specimen identification and antimicrobial susceptibility testing of major bloodborne bacterial pathogens. The project will develop a regulatory pathway for FDA clearance, characterize antibodies to expand the test, and validate the expanded tests...